Risklick and Citeline Partner to Accelerate AI-Driven Clinical Trial Protocol Development

Risklick has entered into a strategic partnership with Citeline, a global leader in clinical data and intelligence, to advance AI-driven clinical trial protocol development and help sponsors design higher-quality, more efficient clinical studies.

Clinical trial protocols are becoming increasingly complex, leading to costly amendments, extended timelines, and operational inefficiencies. Through this collaboration, Citeline’s proprietary clinical data and AI capabilities will be combined with Risklick’s protocol authoring and design expertise, enabling a more data-driven, end-to-end approach to protocol development.

The partnership aims to support clinical teams in optimizing critical protocol elements such as study design, eligibility criteria, and endpoints, while reducing avoidable risks early in the planning phase.

“By partnering with Risklick, we are transforming protocol design from a manual hurdle into a high-speed, AI-driven engine for smarter trials,” said Suzanne Caruso, General Manager at Citeline. “This collaboration brings together our deep clinical intelligence with Risklick’s innovative workflow to help sponsors move faster with greater confidence.”

Risklick’s AI-powered platform is designed to streamline protocol creation, align stakeholders earlier, and minimize downstream amendments — a key driver of delays and cost overruns in clinical research.

“Our mission is to enable the pharmaceutical industry to design a clinical study in just one day,” said Dr. Poorya Amini, Founder and CEO of Risklick. “Partnering with Citeline allows us to enhance our platform with best-in-class clinical data, empowering teams to design smarter, patient-centered protocols from the very beginning.”

By integrating Citeline’s real-world clinical insights directly into Risklick’s protocol workflow, the collaboration supports a more holistic and scalable approach to trial design — bridging strategy, data, and execution.

About Risklick

Risklick is a Swiss technology company specializing in AI-driven clinical trial protocol development. Its platform helps pharmaceutical and biotech companies reduce protocol complexity, mitigate risks early, and accelerate clinical development through smarter study design.

About Citeline

Citeline is a leading provider of clinical data, analytics, and intelligence, supporting the global life sciences industry with insights that connect research, development, and commercialization.

Link to the original Press Release: Citeline

Citeline PR contact:

Diffusion PR for Citeline
citeline@diffusionpr.com
(213) 318-4500

Risklick PR contact:
support@risklick.ch